Lv2
118 积分 2022-05-16 加入
Discovery of Potent FGFR2/3 Inhibitors to Overcome Mutation Resistance and Treat Achondroplasia
1天前
已完结
Design, synthesis and antitumor activity of a novel FGFR2-selective degrader to overcome resistance of the FGFR2V564F gatekeeper mutation based on a pan-FGFR inhibitor,
1天前
已完结
Molecular Modeling, de novo Design and Synthesis of a Novel, Extracellular Binding Fibroblast Growth Factor Receptor 2 Inhibitor Alofanib (RPT835)
1天前
已完结
Electron-density informed effective and reliable de novo molecular design and lead optimization with ED2Mol
1个月前
已完结
Product Subclass 2: Ortho Esters and Halogenated Derivatives
2个月前
已完结
FGFR rearrangements: oncogenic drivers and therapeutic targets
3个月前
已关闭
Brain Penetrant NLRP3 Inhibitors: The Discovery of a Panacea?
5个月前
已完结
Negative Allosteric Modulators of A2AR: A New Weapon for Cancer Immunotherapy?
5个月前
已完结
Turning Off STAT6 with a Targeted Degrader
5个月前
已完结
MDM2 Degrader as a Promising Therapeutic Strategy for Cancer Treatment
5个月前
已完结
皖公网安备34019202002308
